Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 3/20 | 0.50 |
| ▸ | CA1 | P00915 | 3/20 | 0.50 |
| ▸ | CA2 | P00918 | 3/20 | 0.50 |
| ▸ | CA9 | Q16790 | 3/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.50 |
| ▸ | CA7 | P43166 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.48 |
| ▸ | POLB | P06746 | 3/20 | 0.48 |
| ▸ | XDH | P47989 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | GFER | P55789 | 1/20 | 0.48 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.48 |
| ▸ | RELA | Q04206 | 1/20 | 0.48 |
| ▸ | FUT7 | Q11130 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4599408 | 0.96 | CA12 (0.50) | CA12CA1CA2CA9CA14 | |
| SCHEMBL13790627 | 0.93 | ALDH1A1 (0.45) | CA12CA1CA2CA9CA14 | |
| SCHEMBL24298202 | 0.89 | CNR2 (0.46) | CA12CA1CA2CA9CA14 | |
| SCHEMBL3593345 | 0.89 | ALDH1A1 (0.46) | CA12CA1CA2CA9CA14 | |
| SCHEMBL19900071 | 0.88 | CA12 (0.43) | CA12CA1CA2CA9CA14 | |
| SCHEMBL22012125 | 0.88 | CA12 (0.43) | CA12CA1CA2CA9CA14 | |
| SCHEMBL16903501 | 0.88 | NOTUM (0.55) | CA12CA1CA2CA9CA14 | |
| SCHEMBL3593036 | 0.85 | NOTUM (0.60) | CA12CA1CA2CA9CA14 | |
| SCHEMBL22021470 | 0.84 | CA12 (0.40) | CA12CA1CA2CA9CA14 | |
| SCHEMBL27574884 | 0.82 | ALDH1A1 (0.41) | CA12CA1CA2CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3421548-B1 | COLORING COMPOSITION, INKJET RECORDING INK, INKJET RECORDING METHOD, AND INKJET PRINTER CARTRIDGE | FUJIFILM CORP (JP) | 2024-01-24 | — | — | EP | disclosed |
| EP-3421547-B1 | COLORING COMPOSITION, INK JET RECORDING INK, INK JET RECORDING METHOD, AND INK JET PRINTER CARTRIDGE | FUJIFILM CORP (JP) | 2023-12-20 | — | — | EP | disclosed |
| EP-3421549-B1 | COLORING COMPOSITION, INKJET RECORDING INK, INKJET RECORDING METHOD, AND INKJET PRINTER CARTRIDGE | FUJIFILM CORP (JP) | 2023-08-16 | — | — | EP | disclosed |
| US-20230051589-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY | NOVARTIS AG (CH) | 2023-02-16 | — | — | US | disclosed |
| CN-108699349-B | Coloring composition, ink for inkjet recording, inkjet recording method, and ink cartridge for inkjet printer | 富士胶片株式会社 | 2021-03-12 | — | — | CN | disclosed |
| CN-108699350-B | Coloring composition, ink for inkjet recording, inkjet recording method, and ink cartridge for inkjet printer | 富士胶片株式会社 | 2021-03-12 | — | — | CN | disclosed |
| CN-108699348-B | Coloring composition, ink for inkjet recording, inkjet recording method, and ink cartridge for inkjet printer | 富士胶片株式会社 | 2021-03-12 | — | — | CN | disclosed |
| US-10745577-B2 | Aqueous solution, coloring composition, ink jet recording ink, ink jet recording method, and ink cartridge | FUJIFILM CORPORATION (JP) | 2020-08-18 | — | — | US | disclosed |
| US-10711148-B2 | Coloring composition, ink jet recording ink, ink jet recording method, and ink jet printer cartridge | FUJIFILM CORPORATION (JP) | 2020-07-14 | — | — | US | disclosed |
| US-10711148-B2 | Coloring composition, ink jet recording ink, ink jet recording method, and ink jet printer cartridge | FUJIFILM CORPORATION (JP) | 2020-07-14 | — | — | US | disclosed |
| US-6468729-B2 | Silver halide photographic light-sensitive material | FUJI PHOTO FILM CO., LTD. (JP) | 2002-10-22 | — | — | US | disclosed |
| US-20010031433-A1 | Silver halide photographic light-sensitive material | FUJIFILM CORPORATION (JP) | 2001-10-18 | — | — | US | disclosed |
| EP-1132770-A2 | Silver halide photographic light-sensitive material | Fuji Photo Film Co., Ltd. (JP) | 2001-09-12 | — | — | EP | disclosed |
| WO-1996034851-A1 | BENZENE, PYRIDINE, NAPHTALENE OR BENZOPHENONE DERIVATIVES AS INHIBITORS OF SQUALENE SYNTHETASE AND PROTEIN FARNESYLTRANSFERASE | ABBOTT LABORATORIES (US) | 1996-11-07 | — | — | WO | disclosed |
| US-5312724-A | Support with layer containing indoaniline dye which has at least three acidic substituents | FUJI PHOTO FILM CO., LTD. (JP) | 1994-05-17 | — | — | US | disclosed |
| EP-0368429-B1 | Fluor-substituted benzene derivatives | SCHERING AG (DE) | 1994-02-09 | — | — | EP | disclosed |
| US-5130119-A | Sulfonamide or hydroxy fluorine substituted benzene for medical diagnosis | SCHERING AKTIENGESELLSCHAFT (DE) | 1992-07-14 | — | — | US | disclosed |
| EP-0368429-A2 | Fluor-substituted benzene derivatives | SCHERING AKTIENGESELLSCHAFT (DE) | 1990-05-16 | — | — | EP | disclosed |
| US-4035346-A | ANTISTATIC | E. I. DU PONT DE NEMOURS AND CO. (US) | 1977-07-12 | — | — | US | disclosed |
| US-4006123-A | Conductive aliphatic polyester or polyetherester having units containing phosphonium sulfonate groups | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230051589-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY | NLRP1, NLRP3, NOD1 | CA12 2844/4885CA1 3732/4885CA2 1210/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.